FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Waddington

Research Profile

Disorders

Chemicals & Drugs

Activities & Behaviors

Living Beings

Co-author Network

Publications

TOP 3
Babovic Daniela; Ilse Gantois; Satoshi Goto; Luning Jiang; Andrew J Lawrence; Günter Schütz; John L Waddington; John Drago
Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine.
Colm M O'Tuathaigh; Emilie Petit; Orna Tighe; Jeremy Walsh; Gerard Clarke; Niamh Clarke; John F Cryan; Lieve Desbonnet; Ted G Dinan; Joseph A Gogos; Maria Karayiorgou; Claire O'Leary; John L Waddington
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
Kazunori Adachi; Toshiyuki Kawasaki; Masayuki Kobayashi; Hirotaka Onoe; Hiroshi Sakagami; John L Waddington; Chihiro Yokoyama; Noriaki Koshikawa
Disruption of programmed masticatory movements in unilateral MPTP-treated monkeys as a model of jaw movement abnormality in Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Waddington (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Babovic Daniela; Ilse Gantois; Satoshi Goto; Luning Jiang; Andrew J Lawrence; Günter Schütz; John L Waddington; John Drago
Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine.
Journal of pharmacological sciences 2013;121(1):39-47.
2012: Colm M O'Tuathaigh; Emilie Petit; Orna Tighe; Jeremy Walsh; Gerard Clarke; Niamh Clarke; John F Cryan; Lieve Desbonnet; Ted G Dinan; Joseph A Gogos; Maria Karayiorgou; Claire O'Leary; John L Waddington
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(9):1331-42.
2012: Kazunori Adachi; Toshiyuki Kawasaki; Masayuki Kobayashi; Hirotaka Onoe; Hiroshi Sakagami; John L Waddington; Chihiro Yokoyama; Noriaki Koshikawa
Disruption of programmed masticatory movements in unilateral MPTP-treated monkeys as a model of jaw movement abnormality in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(8):933-41.
2012: Eva M Jimenez-Mateos; Ross C McKiernan; Paula Merino-Serrais; Genshin Mouri; Donncha F O'Brien; Colm M O'Tuathaigh; Suzanne Prenter; Takanori Sano; Raymond L Stallings; Katsuhiro Tanaka; John L Waddington; Ronán M Conroy; Javier DeFelipe; Norman Delanty; Tobias Engel; Michael A Farrell; David C Henshall
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects.
Nature medicine 2012;18(7):1087-94.
2012: J Walsh; John L Waddington; N Clarke; Lieve Desbonnet; Colm M O'Tuathaigh
Disruption of exploratory and habituation behavior in mice with mutation of DISC1: an ethologically based analysis.
Journal of neuroscience research 2012;90(7):1445-53.
2012: Aine T Behan; Mary Cannon; Joseph A Gogos; Magdalena Hryniewiecka; Maria Karayiorgou; Anthony Kinsella; Colm M O'Tuathaigh; John L Waddington; David R Cotter
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(7):1773-83.
2012: Colm M O'Tuathaigh; Lieve Desbonnet; Peter Lee; John L Waddington
Catechol-O-methyl transferase as a drug target for schizophrenia.
CNS & neurological disorders drug targets 2012;11(3):282-91.
2012: Lieve Desbonnet; Timothy G Dinan; Richard Harvey; Donna Lai; Claire O'Leary; Colm M O'Tuathaigh; Emilie Petit; Orna Tighe; Gerard Clarke; Niamh Clarke; John F Cryan; John L Waddington
Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene × environment interaction.
Brain, behavior, and immunity 2012;26(4):660-71.
2012: Lieve Desbonnet; Joseph A Gogos; Maria Karayiorgou; Orna Tighe; John L Waddington; Colm M O'Tuathaigh
Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice.
Behavioural brain research 2012;228(2):351-8.
2012: Colm M O'Tuathaigh; Lieve Desbonnet; John L Waddington
Mutant mouse models in evaluating novel approaches to antipsychotic treatment.
Handbook of experimental pharmacology 2012;(213):113-45.
2012: Katsunori Tomiyama; John L Waddington; John Drago; Noriaki Koshikawa
Constitutive and conditional mutant mouse models for understanding dopaminergic regulation of orofacial movements: emerging insights and challenges.
Journal of pharmacological sciences 2012;119(4):297-301.
2012: Colm M O'Tuathaigh; Lieve Desbonnet; Paula M Moran; John L Waddington
Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology.
Current topics in behavioral neurosciences 2012;12():209-50.
2011: Katsunori Tomiyama; John L Waddington; Michelle E Ehrlich; Hyun Ah Kim; Anthony Kinsella; Noriaki Koshikawa; Andrew J Lawrence; Günter Schütz; John Drago
Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.
Synapse (New York, N.Y.) 2011;65(9):835-42.
2011: Annette Rünker; John L Waddington; Derek W Morris; Colm M O'Tuathaigh; Aiden Corvin; Mark dunleavy; Michael Gill; David C Henshall; Graham E Little; Kevin J Mitchell
Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology.
PloS one 2011;6(11):e26488.
2011: Katsunori Tomiyama; Colm M O'Tuathaigh; John L Waddington
Regulation of orofacial movement: amino acid mechanisms and mutant models.
International review of neurobiology 2011;97():61-75.
2011: John L Waddington; Gerard J O'Sullivan; Katsunori Tomiyama
Regulation of orofacial movement: dopamine receptor mechanisms and mutant models.
International review of neurobiology 2011;97():39-60.
2011: Colm M O'Tuathaigh; Lieve Desbonnet; Paula M Moran; Brian P Kirby; John L Waddington
Molecular genetic models related to schizophrenia and psychotic illness: heuristics and challenges.
Current topics in behavioral neurosciences 2011;7():87-119.
2010: Colm M O'Tuathaigh; Magdalena Hryniewiecka; Aine Behan; Orna Tighe; Catherine Coughlan; Lieve Desbonnet; Mary Cannon; Maria Karayiorgou; Joseph A Gogos; David R Cotter; John L Waddington
Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(11):2262-73.
2010: Brian P Kirby; John L Waddington; Colm M P O'Tuathaigh
Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption.
Brain research bulletin 2010;83(3-4):162-76.
2010: Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.
Schizophrenia research 2010;122(1-3):63-71.
2010: E Cummings; Gary Donohoe; C McDonald; Timothy G Dinan; F Anthony O'Neill; Eadbhard O'Callaghan; John L Waddington; K C Murphy; Michael Gill; Derek W Morris; Aiden Corvin
Clinical symptomatology and the psychosis risk gene ZNF804A.
Schizophrenia research 2010;122(1-3):273-5.
2010: Katsunori Tomiyama; Liqiu Song; Masayuki Kobayashi; Anthony Kinsella; Takashi Kanematsu; Masato Hirata; Noriaki Koshikawa; John L Waddington
Orofacial movements in phospholipase C-related catalytically inactive protein-1/2 double knockout mice: Effect of the GABAergic agent diazepam and the D(1) dopamine receptor agonist SKF 83959.
Synapse (New York, N.Y.) 2010;64(9):714-20.
2010: J Walsh; Orna Tighe; D Lai; R Harvey; Maria Karayiorgou; Joseph A Gogos; John L Waddington; Colm M O'Tuathaigh
Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1.
Brain research 2010;1348():114-9.
2010: Satoshi Fujita; Motori Kiguchi; Masayuki Kobayashi; Anthony Kinsella; Noriaki Koshikawa; John L Waddington
Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
European journal of pharmacology 2010;632(1-3):39-44.
2010: Satoshi Fujita; Motori Kiguchi; Masayuki Kobayashi; Noriaki Koshikawa; John L Waddington
Involvement of NMDA receptors in the ventrolateral striatum of rats in apomorphine-induced jaw movements.
Brain research 2010;1322():30-7.
2010: Babovic Daniela; Luning Jiang; Ilse Gantois; Andrew J Lawrence; Vincenzo Ferreri; Günter Schütz; John L Waddington; John Drago
Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
Behavioural brain research 2010;206(1):78-87.
2010: C M P O'Tuathaigh; M Harte; C O'Leary; Gerard J O'Sullivan; C Blau; D Lai; R P Harvey; Orna Tighe; A J Fagan; C Kerskens; Gavin Reynolds; John L Waddington
Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
The European journal of neuroscience 2010;31(2):349-58.
2009: Lieve Desbonnet; John L Waddington; Colm M P O Tuathaigh
Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?
Behavioural brain research 2009;204(2):258-73.
2009: Katsunori Tomiyama; Colm M O'Tuathaigh; Gerard J O'Sullivan; Anthony Kinsella; Donna Lai; Richard P Harvey; Orna Tighe; David T Croke; Noriaki Koshikawa; John L Waddington
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(2):330-3.
2008: Mao Sheng Yang; Derek W Morris; Gary Donohoe; Elaine Kenny; Colm O'Dushlaine; Siobhan Schwaiger; Jeanne-Marie Nangle; Sarah Clarke; Paul Scully; John Quinn; David Meagher; Patrizia Baldwin; Niall Crumlish; Eadbhard O'Callaghan; John L Waddington; Michael Gill; Aiden Corvin
Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.
Biological psychiatry 2008;64(2):98-103.
2008: John L Waddington; Alan S Brown; Abbie Lane; Catherine A Schaefer; Raymond R Goetz; Michaeline Bresnahan; Ezra S Susser
Congenital anomalies and early functional impairments in a prospective birth cohort: risk of schizophrenia-spectrum disorder in adulthood.
The British journal of psychiatry : the journal of mental science 2008;192(4):264-7.
2008: Colm M O'Tuathaigh; Anne-Marie O'Connor; Gerard J O'Sullivan; Donna Lai; Richard Harvey; David T Croke; John L Waddington
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(2):462-6.
2008: Derek W Morris; Kevin Murphy; Niamh Kenny; Shaun M Purcell; McGhee Kevin; Siobhan Schwaiger; Jeanne-Marie Nangle; Gary Donohoe; Sarah Clarke; Paul J Scully; John Quinn; David Meagher; Patrizia Baldwin; Niall Crumlish; Eadbhard O'Callaghan; John L Waddington; Michael Gill; Aiden Corvin
Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.
Biological psychiatry 2008;63(1):24-31.
2007: Babovic Daniela; Colm M O'Tuathaigh; Gerard J O'Sullivan; Jeremiah J Clifford; Orna Tighe; David T Croke; Maria Karayiorgou; Joseph A Gogos; David Cotter; John L Waddington
Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice.
Behavioural brain research 2007;183(2):236-9.
2007: Aiden Corvin; McGhee Kevin; Kevin Murphy; Gary Donohoe; Jeanne-Marie Nangle; Siobhan Schwaiger; Niamh Kenny; Sarah Clarke; David Meagher; John Quinn; Paul J Scully; P Baldwin; D Browne; C Walsh; John L Waddington; Derek W Morris; Michael Gill
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(7):949-53.
2007: John L Waddington; Aiden Corvin; Gary Donohoe; Colm M O'Tuathaigh; Kevin J Mitchell; Michael Gill
Functional genomics and schizophrenia: endophenotypes and mutant models.
The Psychiatric clinics of North America 2007;30(3):365-99.
2007: Colm M O'Tuathaigh; Babovic Daniela; Gerard J O'Sullivan; Jeremiah J Clifford; Orna Tighe; David T Croke; R Harvey; John L Waddington
Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.
Neuroscience 2007;147(1):18-27.
2007: Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Three-dimensional laser surface imaging and geometric morphometrics resolve frontonasal dysmorphology in schizophrenia.
Biological psychiatry 2007;61(10):1187-94.
2007: Yasuyuki Makihara; Yaeko Okuda; Chieko Kawada; Mitsuhiko Matsumoto; John L Waddington; Noriaki Koshikawa; Katsunori Tomiyama
Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
Neuroscience letters 2007;415(1):6-10.
2007: Colm M O'Tuathaigh; Babovic Daniela; Gillian O'Meara; Jeremiah J Clifford; David T Croke; John L Waddington
Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.
Neuroscience and biobehavioral reviews 2007;31(1):60-78.
2006: Katsunori Tomiyama; Yasuyuki Makihara; Hiroshi Yamamoto; Gerard O'Sullivan; Rachel E Nally; Orna Tighe; Anthony Kinsella; Allen Fienberg; David K Grandy; David R Sibley; David T Croke; Noriaki Koshikawa; John L Waddington
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(6):437-45.
2006: Satoshi Fujita; Jun Lee; Motori Kiguchi; Takuya Uchida; Alexander R Cools; John L Waddington; Noriaki Koshikawa
Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
European journal of pharmacology 2006;538(1-3):94-100.
2006: Gerard J O'Sullivan; Anthony Kinsella; David K Grandy; Orna Tighe; David T Croke; John L Waddington
Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions.
Synapse (New York, N.Y.) 2006;59(2):107-18.
2006: Colm M O'Tuathaigh; Gerard J O'Sullivan; Anthony Kinsella; Richard P Harvey; Orna Tighe; David T Croke; John L Waddington
Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice.
Neuroreport 2006;17(1):79-83.
2006: Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul R Buckland; John L Waddington; Michael Gill; Aiden Corvin; Michael J Owen; Michael C O'Donovan
Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(1):96-101.
2006: Robin J Hennessy; Stephen McLearie; Anthony Kinsella; John L Waddington
Facial shape and asymmetry by three-dimensional laser surface scanning covary with cognition in a sexually dimorphic manner.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(1):73-80.
2005: John L Waddington; Colm M O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.
Psychopharmacology 2005;181(4):611-38.
2005: Robin J Hennessy; Stephen McLearie; Anthony Kinsella; John L Waddington
Facial surface analysis by 3D laser scanning and geometric morphometrics in relation to sexual dimorphism in cerebral--craniofacial morphogenesis and cognitive function.
Journal of anatomy 2005;207(3):283-95.
2005: McGhee Kevin; Derek W Morris; Siobhan Schwaiger; Jeanne-Marie Nangle; Gary Donohoe; Sarah Clarke; David Meagher; John Quinn; Paul J Scully; John L Waddington; Michael Gill; Aiden Corvin
Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs.
Schizophrenia research 2005;76(2-3):231-8.
2005: Patrizia Baldwin; David Browne; Paul J Scully; John F Quinn; Maria G Morgan; Anthony Kinsella; John M Owens; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years.
Schizophrenia bulletin 2005;31(3):624-38.
2005: Gerard J O'Sullivan; Anthony Kinsella; David R Sibley; Orna Tighe; David T Croke; John L Waddington
Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
Synapse (New York, N.Y.) 2005;55(4):201-11.
2004: Yasuyuki Makihara; Hiroshi Yamamoto; Mai Inoue; Katsunori Tomiyama; Noriaki Koshikawa; John L Waddington
Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent.
Journal of psychopharmacology (Oxford, England) 2004;18(4):484-95.
2004: Rachel E Nally; Anthony Kinsella; Orna Tighe; David T Croke; Allen Fienberg; Paul Greengard; John L Waddington
Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background.
The Journal of pharmacology and experimental therapeutics 2004;310(3):1281-7.
2004: Gerard J O'Sullivan; Jeremiah J Clifford; Katsunori Tomiyama; Noriaki Koshikawa; John Drago; David R Sibley; David T Croke; John L Waddington
D1-like dopamine receptor-mediated function in congenic mutants with D1 vs. D5 receptor "knockout".
Journal of receptor and signal transduction research 2004;24(3):107-16.
2004: David Meagher; John F Quinn; Stephanie Bourke; Sally Linehan; Patrice Murphy; Anthony Kinsella; James Mullaney; John L Waddington
Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population.
Psychiatry research 2004;126(3):217-27.
2004: Nigel M Williams; Anna Preece; Derek W Morris; Gillian Spurlock; Nicholas J Bray; M Stephens; Nadine Norton; Hywel Williams; M Clement; Sarah Dwyer; C Curran; J Wilkinson; Valentina Moskvina; John L Waddington; Michael Gill; Aiden Corvin; Stanley Zammit; George Kirov; Michael J Owen; Michael C O'Donovan
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
Archives of general psychiatry 2004;61(4):336-44.
2004: Robin J Hennessy; Abbie Lane; Anthony Kinsella; Conall Larkin; Eadbhard O'Callaghan; John L Waddington
3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia.
Schizophrenia research 2004;67(2-3):261-8.
2004: Paul J Scully; John M Owens; Anthony Kinsella; John L Waddington
Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate.
Schizophrenia research 2004;67(2-3):143-55.
2004: Gerard J O'Sullivan; Bryan L Roth; Anthony Kinsella; John L Waddington
SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
European journal of pharmacology 2004;486(3):273-80.
2004: Derek W Morris; Alana Rodgers; McGhee Kevin; Siobhan Schwaiger; Paul J Scully; John Quinn; David Meagher; John L Waddington; Michael Gill; Aiden Corvin
Confirming RGS4 as a susceptibility gene for schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;125B(1):50-3.
2004: Aiden Corvin; Derek W Morris; McGhee Kevin; Siobhan Schwaiger; Paul J Scully; John Quinn; David Meagher; D St Clair; John L Waddington; Michael Gill
Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.
Molecular psychiatry 2004;9(2):208-13.
2004: Katsunori Tomiyama; Fergal N McNamara; Jeremiah J Clifford; Anthony Kinsella; John Drago; Sara Fuchs; David K Grandy; Malcolm J Low; Marcelo Rubinstein; Orna Tighe; David T Croke; Noriaki Koshikawa; John L Waddington
Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout".
Synapse (New York, N.Y.) 2004;51(1):71-81.
2003: Rachel E Nally; Fergal N McNamara; Jeremiah J Clifford; Anthony Kinsella; Orna Tighe; David T Croke; Allen Fienberg; Paul Greengard; John L Waddington
Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(12):2055-63.
2003: Kazunori Adachi; Megumi Hasegawa; Satoshi Fujita; Jun Lee; Alexander R Cools; John L Waddington; Noriaki Koshikawa
Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
European journal of pharmacology 2003;473(1):47-54.
2003: Derek W Morris; McGhee Kevin; Siobhan Schwaiger; Paul J Scully; John Quinn; David Meagher; John L Waddington; Michael Gill; Aiden Corvin
No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.
Schizophrenia research 2003;60(2-3):167-72.
2003: Maria G Morgan; Paul J Scully; Hanafy A Youssef; Anthony Kinsella; John M Owens; John L Waddington
Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural Ireland.
Psychiatry research 2003;117(2):127-35.
2003: Fergal N McNamara; Jeremiah J Clifford; Orna Tighe; Anthony Kinsella; John Drago; David T Croke; John L Waddington
Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(1):86-99.
2002: Fergal N McNamara; Jeremiah J Clifford; Orna Tighe; Anthony Kinsella; John Drago; Sara Fuchs; David T Croke; John L Waddington
Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout".
Synapse (New York, N.Y.) 2002;46(1):19-31.
2002: Paul J Scully; John F Quinn; Maria G Morgan; Anthony Kinsella; Eadbhard O'Callaghan; John M Owens; John L Waddington
First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years.
The British journal of psychiatry. Supplement 2002;43():s3-9.
2002: Katsunori Tomiyama; Fergal N McNamara; Jeremiah J Clifford; Anthony Kinsella; John Drago; Orna Tighe; David T Croke; Noriaki Koshikawa; John L Waddington
Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' mice.
Neuropharmacology 2002;42(5):644-52.
2002: Robin J Hennessy; Anthony Kinsella; John L Waddington
3D laser surface scanning and geometric morphometric analysis of craniofacial shape as an index of cerebro-craniofacial morphogenesis: initial application to sexual dimorphism.
Biological psychiatry 2002;51(6):507-14.
2002: Paul J Scully; John M Owens; Anthony Kinsella; John L Waddington
Dimensions of psychopathology in bipolar disorder versus other affective and non-affective psychoses among an epidemiologically complete population.
Bipolar disorders 2002;4 Suppl 1():43-4.
2002: P A Baldwin; Paul J Scully; John F Quinn; Maria G Morgan; Anthony Kinsella; Eadbhard O'Callaghan; John M Owens; John L Waddington
First episode bipolar disorder: systematic comparison of incidence with other affective and non-affective psychoses among an epidemiologically complete, rural population.
Bipolar disorders 2002;4 Suppl 1():39-40.
2002: Jeremiah J Clifford; John Drago; AL Natoli; John Y F Wong; Anthony Kinsella; John L Waddington; K S Vaddadi
Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease.
Neuroscience 2002;109(1):81-8.
2001: Jeremiah J Clifford; Anthony Kinsella; Orna Tighe; M Rubinstein; David K Grandy; Malcolm J Low; David T Croke; John L Waddington
Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(4):527-36.
2001: Megumi Hasegawa; Kazunori Adachi; Shin Nakamura; Michiko Sato; John L Waddington; Noriaki Koshikawa
Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
European journal of pharmacology 2001;423(2-3):171-8.
2001: John L Waddington; Paul J Scully; J F Quinn; David Meagher; Maria G Morgan
The origin and course of schizophrenia: implications for clinical practice.
Journal of psychiatric practice 2001;7(4):247-52.
2001: David Meagher; John Quinn; P Murphy; A Kinsella; James Mullaney; John L Waddington
Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics.
Schizophrenia research 2001;50(1-2):95-103.
2001: John L Waddington; Jeremiah J Clifford; Fergal N McNamara; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout').
Progress in neuro-psychopharmacology & biological psychiatry 2001;25(4):925-64.
2001: Katsunori Tomiyama; Fergal N McNamara; Jeremiah J Clifford; Anthony Kinsella; Noriaki Koshikawa; John L Waddington
Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation.
European journal of pharmacology 2001;418(1-2):47-54.
2001: John Quinn; David Meagher; P Murphy; A Kinsella; James Mullaney; John L Waddington
Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
Schizophrenia research 2001;49(1-2):79-87.
2000: J Quinn; M Moran; A Lane; A Kinsella; John L Waddington
Long-term adaptive life functioning in relation to initiation of treatment with antipsychotics over the lifetime trajectory of schizophrenia.
Biological psychiatry 2000;48(2):163-6.
2000: Jeremiah J Clifford; John L Waddington
Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(5):538-44.
2000: Jeremiah J Clifford; Alessandro Usiello; Daniela Vallone; Anthony Kinsella; Emiliana Borrelli; John L Waddington
Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor.
Neuropharmacology 2000;39(3):382-90.
1999: John L Waddington; A Lane; Paul J Scully; David Meagher; John Quinn; C Larkin; Eadbhard O'Callaghan
Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process.
Journal of psychiatric research 1999;33(6):477-89.
1999: John L Waddington; A Lane; C Larkin; Eadbhard O'Callaghan
The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.
Biological psychiatry 1999;46(1):31-9.
1999: Hanafy A Youssef; Paul J Scully; Anthony Kinsella; John L Waddington
Geographical variation in rate of schizophrenia in rural Ireland by place at birth vs place at onset.
Schizophrenia research 1999;37(3):233-43.
1999: Kazunori Adachi; Hiroko Ikeda; Megumi Hasegawa; Shin Nakamura; John L Waddington; Noriaki Koshikawa
SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
European journal of pharmacology 1999;367(2-3):143-9.
1999: Jeremiah J Clifford; Orna Tighe; David T Croke; Anthony Kinsella; David R Sibley; John Drago; John L Waddington
Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
Neuroscience 1999;93(4):1483-9.
1998: Jeremiah J Clifford; Orna Tighe; David T Croke; David R Sibley; John Drago; John L Waddington
Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax.
Neuropharmacology 1998;37(12):1595-602.
1998: John L Waddington; Hanafy A Youssef; Anthony Kinsella
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study.
The British journal of psychiatry : the journal of mental science 1998;173():325-9.
1998: John L Waddington; Peter F Buckley; Paul J Scully; A Lane; Eadbhard O'Callaghan; C Larkin
Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics?
Journal of psychiatric research 1998;32(3-4):179-89.
1998: Jeremiah J Clifford; John L Waddington
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach.
Psychopharmacology 1998;136(3):284-90.
1998: John L Waddington; A Lane; Paul J Scully; C Larkin; Eadbhard O'Callaghan
Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?
The Psychiatric clinics of North America 1998;21(1):123-49.
1998: John L Waddington; A M Deveney; Jeremiah J Clifford; Orna Tighe; David T Croke; David R Sibley; John Drago
Behavioral analysis of multiple D1-like dopamine receptor subtypes: new agents and studies in transgenic mice with D1A receptor knockout.
Advances in pharmacology (San Diego, Calif.) 1998;42():514-7.
1997: John L Waddington; Paul J Scully; Eadbhard O'Callaghan
The new antipsychotics, and their potential for early intervention in schizophrenia.
Schizophrenia research 1997;28(2-3):207-22.
1997: Paul J Scully; G Coakley; Anthony Kinsella; John L Waddington
Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia.
Psychological medicine 1997;27(6):1303-10.
1997: A M Deveney; John L Waddington
Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
Pharmacology, biochemistry, and behavior 1997;58(2):551-8.
1997: Paul J Scully; G Coakley; Anthony Kinsella; John L Waddington
Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in 'static' v. 'progressive' profiles.
The British journal of psychiatry : the journal of mental science 1997;171():154-8.
1997: John L Waddington
Do D2-like dopamine receptors mediate neuronal excitation or inhibition: some functional-behavioural implications.
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 1997;17(2):111-2.
1997: John L Waddington; Paul J Scully; Hanafy A Youssef
Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101.
Schizophrenia research 1997;23(2):107-18.
1996: A M Deveney; John L Waddington
Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
European journal of pharmacology 1996;317(2-3):175-81.
1996: John L Waddington; Hanafy A Youssef
Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological medicine 1996;26(4):681-8.
1996: A M Deveney; John L Waddington
Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Psychopharmacology 1996;124(1-2):40-9.
1996: John L Waddington; A M Deveney
Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.
Biochemical Society transactions 1996;24(1):177-82.
1996: John L Waddington; Hanafy A Youssef
Familial-genetic and reproductive epidemiology of schizophrenia in rural Ireland: age at onset, familial morbid risk and parental fertility.
Acta psychiatrica Scandinavica 1996;93(1):62-8.
1995: John L Waddington; Hanafy A Youssef; M A Farrell; J Toland
Initial 'schizophrenia-like' psychosis in Pick's disease: case study with neuroimaging and neuropathology, and implications for frontotemporal dysfunction in schizophrenia.
Schizophrenia research 1995;18(1):79-82.
1995: Eadbhard O'Callaghan; Peter F Buckley; C Madigan; O Redmond; J P Stack; Anthony Kinsella; Conall Larkin; JT Ennis; John L Waddington
The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging.
Biological psychiatry 1995;38(8):516-24.
1995: A M Deveney; John L Waddington
Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
British journal of pharmacology 1995;116(3):2120-6.
1995: John L Waddington; S A Daly; R P Downes; A M Deveney; P G McCauley; K M O'Boyle
Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(5):811-31.
1995: Peter F Buckley; Eadbhard O'Callaghan; F Mulvany; Conall Larkin; J P Stack; O Redmond; JT Ennis; P Thompson; John L Waddington
Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
Psychiatry research 1995;61(2):95-102.
1995: P G McCauley; K M O'Boyle; John L Waddington
Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions.
Neuropharmacology 1995;34(7):777-83.
1995: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; C Madigan; O Redmond; J P Stack; Anthony Kinsella; Conall Larkin; JT Ennis
Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
The British journal of psychiatry : the journal of mental science 1995;167(1):41-4.
1995: John L Waddington; Hanafy A Youssef; Anthony Kinsella
Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia.
Psychological medicine 1995;25(4):849-57.
1995: A Lane; M Byrne; F Mulvany; A Kinsella; John L Waddington; D Walsh; Conall Larkin; Eadbhard O'Callaghan
Reproductive behaviour in schizophrenia relative to other mental disorders: evidence for increased fertility in men despite decreased marital rate.
Acta psychiatrica Scandinavica 1995;91(4):222-8.
1995: John L Waddington
Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
Advances in neurology 1995;65():211-29.
1994: Peter F Buckley; C Moore; H Long; Conall Larkin; P Thompson; F Mulvany; O Redmond; J P Stack; JT Ennis; John L Waddington
1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.
Biological psychiatry 1994;36(12):792-800.
1994: S A Daly; John L Waddington
The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
British journal of pharmacology 1994;113(3):839-44.
1994: John L Waddington; H A Youssef
Evidence for a gender-specific decline in the rate of schizophrenia in rural Ireland over a 50-year period.
The British journal of psychiatry : the journal of mental science 1994;164(2):171-6.
1994: John L Waddington; J A Lieberman
New insights into classical issues in schizophrenia.
Journal of psychopharmacology (Oxford, England) 1994;8(1):65-6.
1993: John L Waddington
Sight and insight: "visualisation" of auditory hallucinations in schizophrenia?
Lancet 1993;342(8873):692-3.
1993: Hanafy A Youssef; Anthony Kinsella; John L Waddington
Gender specificity of geographical variation in morbid risk for schizophrenia in rural Ireland.
Acta psychiatrica Scandinavica 1993;88(2):135-9.
1993: S A Daly; John L Waddington
Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists.
Neuropharmacology 1993;32(5):509-10.
1993: R P Downes; John L Waddington
Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
European journal of pharmacology 1993;234(1):135-6.
1993: John L Waddington
Schizophrenia: developmental neuroscience and pathobiology.
Lancet 1993;341(8844):531-6.
1993: Peter F Buckley; J P Stack; C Madigan; Eadbhard O'Callaghan; Conall Larkin; O Redmond; JT Ennis; John L Waddington
Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates.
The American journal of psychiatry 1993;150(1):146-8.
1993: S A Daly; John L Waddington
Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Psychopharmacology 1993;113(1):45-50.
1992: John L Waddington; M P Weller; T J Crow; S R Hirsch
Schizophrenia, genetic retrenchment, and epidemiologic renaissance. The Sixth Biennial Winter Workshop on Schizophrenia, Badgastein, Austria, January 26-February 1, 1992.
Archives of general psychiatry 1992;49(12):990-4.
1992: Eadbhard O'Callaghan; Peter F Buckley; O Redmond; J Stack; JT Ennis; Conall Larkin; John L Waddington
Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis.
Journal of the Royal Society of Medicine 1992;85(4):227-31.
1992: S A Daly; John L Waddington
Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
European journal of pharmacology 1992;213(2):251-8.
1992: S A Daly; John L Waddington
New classes of selective D-1 dopamine receptor antagonist provide further evidence for two directions of D-1:D-2 interaction.
Neurochemistry international 1992;20 Suppl():135S-139S.
1992: K M O'Boyle; John L Waddington
Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
Neuropharmacology 1992;31(2):177-83.
1992: P Bukley; Eadbhard O'Callaghan; Conall Larkin; O Redmond; J Stack; John L Waddington
MRI, cerebral pathology, and schizophrenia.
Biological psychiatry 1992;31(2):209-10.
1992: S A Daly; John L Waddington
D-1 dopamine receptors and the topography of unconditioned motor behaviour: studies with the selective, 'full efficacy' benzazepine D-1 agonist SKF 83189.
Journal of psychopharmacology (Oxford, England) 1992;6(1):50-60.
1992: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; Conall Larkin; O Redmond; J Stack; JT Ennis
MR imaging and spectroscopy in schizophrenia in relation to the neurodevelopmental hypothesis.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():118A-119A.
1991: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; Conall Larkin; O Redmond; J Stack; JT Ennis
The age dependencies of MRI abnormalities in schizophrenia suggest early ventricular enlargement but later prominence of cortical atrophy.
Schizophrenia research 1991;5(3):188-9.
1991: A M Murray; John L Waddington
Age-related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions.
Neurobiology of aging 1991;12(5):431-5.
1991: Eadbhard O'Callaghan; O Redmond; R Ennis; J Stack; Anthony Kinsella; JT Ennis; Conall Larkin; John L Waddington
Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy.
Biological psychiatry 1991;29(11):1149-52.
1991: John L Waddington
The psychopharmacology of D-1 dopamine receptors.
Journal of psychopharmacology (Oxford, England) 1991;5(4):441-2.
1990: John L Waddington; Hanafy A Youssef; Anthony Kinsella
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological medicine 1990;20(4):835-42.
1990: Eadbhard O'Callaghan; Conall Larkin; Anthony Kinsella; John L Waddington
Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia.
The British journal of psychiatry : the journal of mental science 1990;157():578-84.
1990: A M Murray; John L Waddington
The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
European journal of pharmacology 1990;186(1):79-86.
1990: Eadbhard O'Callaghan; Conall Larkin; John L Waddington
Obstetric complications in schizophrenia and the validity of maternal recall.
Psychological medicine 1990;20(1):89-94.
1990: John L Waddington
Neurodevelopmental perspectives of schizophrenia.
Journal of psychopharmacology (Oxford, England) 1990;4(4):245.
1990: John L Waddington; Eadbhard O'Callaghan; Conall Larkin; O Redmond; J Stack; JT Ennis
Magnetic resonance imaging and spectroscopy in schizophrenia.
The British journal of psychiatry. Supplement 1990;(9):56-65.
1990: John L Waddington
Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.
Psychopharmacology 1990;101(4):431-47.
1990: A M Murray; John L Waddington
New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
Pharmacology, biochemistry, and behavior 1990;35(1):105-10.
1989: A M Murray; John L Waddington
Behavioural indices of the interaction of clozapine with D1 and D2 dopamine receptors.
British journal of pharmacology 1989;98 Suppl():814P.
1989: John L Waddington; K Brown; J O'Neill; P McKeon; Anthony Kinsella
Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia.
Psychological medicine 1989;19(4):897-902.
1989: K M O'Boyle; D E Gaitanopoulos; M Brenner; John L Waddington
Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
Neuropharmacology 1989;28(4):401-5.
1989: A M Murray; John L Waddington
The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
European journal of pharmacology 1989;160(3):377-84.
1989: John L Waddington; K M O'Boyle
Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.
Pharmacology & therapeutics 1989;43(1):1-52.
1989: John L Waddington
Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.
International review of neurobiology 1989;31():297-353.
1989: Hanafy A Youssef; John L Waddington
Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia.
International clinical psychopharmacology 1989;4(1):55-9.
1989: A M Murray; John L Waddington
Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.
Psychopharmacology 1989;98(2):245-50.
1988: Hanafy A Youssef; John L Waddington
Calcium metabolism and abnormal involuntary movements (tardive dyskinesia) in psychosis.
Acta psychiatrica Scandinavica 1988;78(4):523-5.
1988: A G Molloy; John L Waddington
Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
British journal of pharmacology 1988;95(2):335-42.
1988: Eadbhard O'Callaghan; Conall Larkin; O Redmond; J Stack; JT Ennis; John L Waddington
'Early-onset schizophrenia' after teenage head injury. A case report with magnetic resonance imaging.
The British journal of psychiatry : the journal of mental science 1988;153():394-6.
1988: John L Waddington; H A Youssef
The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree.
The British journal of psychiatry : the journal of mental science 1988;153():376-81.
1988: John L Waddington; Hanafy A Youssef
Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
The American journal of psychiatry 1988;145(5):613-6.
1988: Hanafy A Youssef; John L Waddington
Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia.
Biological psychiatry 1988;23(8):791-6.
1988: John L Waddington
Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.
General pharmacology 1988;19(1):55-60.
1987: K M O'Boyle; John L Waddington
New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain.
Neuropharmacology 1987;26(12):1807-10.
1987: John L Waddington; Hanafy A Youssef; C Dolphin; Anthony Kinsella
Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
Archives of general psychiatry 1987;44(10):907-12.